Tega Therapeutics Inc.
San Diego, CA
- UEI
- C1LJLCS3PM51
- CAGE
- 6W1N1
- Primary NAICS
- 622110 General Medical and Surgical Hospitals
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3550 General Atomics Ct Ste G02-102, San Diego, CA 92121, USA
- Website
- tegatherapeutics.com
- Founded
- 2014
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Title: new clinical biomarkers for GM1 gamgliosidosis - project summary GM1 gangliosidosis is a lysosomal storage… | National Institute of Neurological Disorders and Stroke | $1,000,000 | |
| Testing novel advancements to recombinant heparin production - project summary heparin is an essential drug, in the form… | National Heart Lung and Blood Institute | $355,222 | |
| Title: development and validation of therapy for GM1 gangliosidosis - project summary GM1 gangliosidosis is lysosomal… | National Institute of Neurological Disorders and Stroke | $461,701 | |
| Developing non-anticoagulant recombinant heparin for treating the copd pathogenic triad - project summary this… | National Heart Lung and Blood Institute | $965,598 | |
| Sbir phase II: development of bioengineered anticoagulant heparin from a non-animal source | National Science Foundation | $1,394,931 |
About Tega Therapeutics Inc.
Tega Therapeutics Inc. is a pharmaceutical research and development company based in San Diego, California, specializing in developing innovative biotechnology solutions for rare diseases and complex medical conditions. Registered in the System for Award Management (SAM) since 2013, the company focuses on engineering advanced therapeutic approaches, particularly in the areas of enzyme replacement therapy and recombinant biological production. The company operates as a for-profit corporate entity and has been actively pursuing federal grant funding to advance its research into novel medical treatments.
Through its federal grant awards, Tega Therapeutics Inc. has secured multiple project grants from prestigious federal agencies including the National Institute of Neurological Disorders and Stroke (NINDS), National Heart Lung and Blood Institute, and the National Science Foundation. The company's grant-funded research has concentrated on developing treatments for rare neurological conditions such as GM1 gangliosidosis, a lysosomal storage disease, and exploring innovative approaches to heparin production using recombinant cell line technologies. Specific project objectives have included engineering mammalian cell lines to produce recombinant enzymes, developing non-anticoagulant heparin for treating chronic obstructive pulmonary disease, and creating alternative production methods for essential medical compounds that currently rely on animal-sourced materials. The company has also received a sub-grant award from the Bioindustrial Manufacturing And Design Ecosystem, indicating its involvement in broader biotechnological innovation networks. These grants, ranging from approximately $461,701 to $500,000, demonstrate Tega Therapeutics' commitment to advancing medical research through federally supported scientific innovation.
Quick answers
What is Tega Therapeutics Inc.'s UEI?
Tega Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is C1LJLCS3PM51.
What is Tega Therapeutics Inc.'s CAGE code?
Tega Therapeutics Inc.'s CAGE code is 6W1N1.
What is Tega Therapeutics Inc.'s primary NAICS code?
Tega Therapeutics Inc.'s primary NAICS code is 622110 (General Medical and Surgical Hospitals).
Where is Tega Therapeutics Inc. located?
Tega Therapeutics Inc.'s physical address in SAM.gov is 3550 General Atomics Ct Ste G02-102, San Diego, CA 92121, USA.
Is Tega Therapeutics Inc. registered in SAM.gov?
Yes. Tega Therapeutics Inc.'s SAM.gov registration is active through September 5, 2027.
What is Tega Therapeutics Inc.'s most recent federal award?
Tega Therapeutics Inc.'s most recent federal grant award is Title: new clinical biomarkers for GM1 gamgliosidosis - project summary GM1 gangliosidosis is a lysosomal storage… (R43NS139721), from National Institute of Neurological Disorders and Stroke, on August 5, 2025.
On GovTribe
See Tega Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors